Mapping of human serum-reactive epitopes in virus-like particles of human papillomavirus types 16 and 11

Virology

Volumn 311, Issue 1, 2003, Pages 213-221

  Wang, Xiaohong ^a   Wang, Zhaohui ^b   Christensen, Neil D ^b   Dillner, Joakim ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Capsids; Hybrid viruslike particles; Immunodominance; Viral serology

Indexed keywords

ANTIBODY; EPITOPE;

ANTIGEN ANTIBODY REACTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHILD; CORRELATION ANALYSIS; GENE MAPPING; HUMAN; HYBRID; NONHUMAN; PRIORITY JOURNAL; SEROLOGY; SERUM; VIRUS CAPSID; VIRUS PARTICLE; VIRUS STRAIN; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 0038045766     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00179-X     Document Type: Article

References (28)

1. af Geijersstam V., Eklund C., Wang Z., Sapp M., Schiller J.T., Dillner J., Dillner L. A survey of seroprevalence of human papillomavirus types 16, 18 and 33 among children. Int. J. Cancer. 80:(4):1999;489-493.
2. Andersson-Ellstrom A., Dillner J., Hagmar B., Schiller J., Sapp M., Forssman L., Milsom I. Comparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. A longitudinal cohort study. Sex Transm. Dis. 23:(3):1996;234-238.
3. Breitburd F., Kimbauer R., Hubbert N.L., Nonnenmacher B., Trin-Dinh-Desmarquet C., Orth G., Schiller J.T., Lowy D.R. Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J. Virol. 69:(6):1995;3959-3963.
4. Cheng G., Lcenogle J.P., Kimbauer R., Hubbert N.L., St. Louis M.E., Han C., Svare E.I., Lowy D.R., Schiller J.T. Divergent human paillomavirus type 16 variants are serologically cross-reactive. J. Infect. Dis. 172:1995;1584-1587.
5. Chen X.S., Garcea R.L., Goldberg I., Casini G., Harrison S.C. Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. Mol. Cell. Biol. 5:(3):2000;557-567.
6. Christensen N.D., Cladel N.M., Reed C.A., Budgeon L.R., Embers M.E., Skulsky D.M., McClements W.L., Ludmerer S.W., Jansen K.U. Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types. Virology. 291:(2):2001;324-334.
7. Christensen N.D., Kreider J.W., Cladel N.M., Patrick S.D., Welsh P.A. Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11. J. Virol. 64:(11):1990;5678-5681.
8. Christensen N.D., Kimbauer R., Schiller J.T., Ghim S.J., Schlegel R., Jenson A.B., Kieider J.W. Human papillomavirus types I and II have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes. Virology. 205:(1):1994;329-335.
9. Christensen N.D., Reed C.A., Cladel N.M., Hall K., Leiserowitz G.S. Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6. Virology. 224:(2):1996;477-486.
10. Christensen N.D., Reed C.A., Cladel N.M., Han R., Kreider J.W. Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus. J. Virol. 70:(2):1996;960-965.
11. Christensen N.D., Dillner J., Eklund C., Carter J.J., Wipf G.C., Reed C.A., Cladel N.M., Galloway D.A. Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies. Virology. 223:(1):1996;174-184.
12. Dillner J., Wiklund F., Lenner P., Eklund C., Frederiksson-Shanazarian V., Schiller J.T., Hibma M., Hallmans G., Stendahl U. Antibodies against linear and conformational epitopes of human papillomavirus type 16 that independently associate with incident cervical cancer. Int. J. Cancer. 60:(3):1995;377-382.
13. Evans T.G., Bonnez W., Rose R.C., Koenig S., Demeter L., Suzich J.A., O'Brien D., Campbell M., White W.I., Balsley J., Reichman R.C. A Phase 1 study of a recombinant viruslike particle vaccine against human papillomavirus type 11 in healthy adult volunteers. J. Infect. Dis. 183:(10):2001;1485-1493.
14. Giroglou T., Sapp M., Lane C., Fligge C., Christensen N.D., Streeck R.E., Rose R.C. Immunological analyses of human papillomavirus capsids. Vaccine. 19:2001;1783-1793.
15. Harro C.D., Pang Y.Y., Roden R.B., Hildesheim A., Wang Z., Reynolds M.J., Mast T.C., Robinson R., Murphy B.R., Karron R.A., Dillner J., Schiller J.T., Lowy D.R. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine. J. Natl. Cancer Inst. 93:(4):2001;284-292.
16. Jenson A.B., Rosenthal J.D., Olson C., Pass F., Lancaster W.D., Shah K.V. Immunologic relatedness of papillomaviruses from different species. J. Natl. Cancer Inst. 64:(3):1980;495-500.
17. Jansen K.U., Rosolowsky M., Schultz L.D., Markus H.Z., Cook J.C., Donnelly J.J., Martinez D., Ellis R.W., Shaw A.R. Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation. Vaccine. 13:(16):1995;1509-1514.
18. Kimbauer R., Chandrachud L.M., O'Neil B.W., Wagner E.R., Grindlay G.J., Armstrong A., McGarvie G.M., Schiller J.T., Lowy D.R., Campo M.S. Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization. Virology. 219:(1):1996;37-44.
19. Ludmerer S.W., Benincasa D., Mark G.E. 3rd. Two amino acid residues confer type specificity to a neutralizing, conformationally dependent epitope on human papillomavirus type 11. J. Virol. 70:(7):1996;4791-4794.
20. Pastrana D.V., Vass W.C., Lowy D.R., Schiller J.T. HPV16 VLP vaccine induces human antibodies that neutralize divergent variants of HPV16. Virology. 279:(1):2001;361-369.
21. Roden R.B., Armstrong A., Haderer P., Christensen N.D., Hubbert N.L., Lowy D.R., Schiller J.T., Kirnbauer R. Characterization of a human papillomavirus type 16 variant-dependent neutralizing epitope. J. Virol. 71:(8):1997;6247-6252.
22. Schiffman M.H., Bauer H.M., Hoover R.N., Glass A.G., Cadell D.M., Rush B.B., Scott D.R., Sherman M.E., Kurman R.J., Wacholder S., et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 85:(12):1993;958-964.
23. Schiller J.T., Hidesheim A. Developing HPV virus-like particle vaccines to prevent cervical cancer a progress report . J. Clin. Virol. 19:(1-2):2000;67-74.
24. Stanley M.A., Moore R.A., Nicholls P.K., Santos E.B., Thomsen L., Parry N., Walcott S., Gough G. Intra-epithelial vaccination with COPV L1 DNA by particle-mediated DNA delivery protects against mucosal challenge with infectious COPV in beagle dogs. Vaccine. 19:(20-22):2001;2783-2792.
25. Suzich J.A., Ghim S.J., Palmer-Hill F.J., White W.I., Tamura J.K., Bell J.A., Newsome J.A., Jenson A.B., Schlegel R. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc. Natl. Acad. Sci. USA. 92:(25):1995;11553-11557.
26. Wang Z., Christensen N., Schiller J.T., Dillner J. A monoclonal antibody against intact human papillomavirus type 16 capsids blocks the serological reactivity of most human sera. J. Gen. Virol. 78:(9):1997;2209-2215.
27. Wang Z., Konya J., Avall-Lundkvist E., Sapp M., Dillner J., Dillner L. Human papillomavirus antibody responses among patients with incident cervical carcinoma. J. Med. Virol. 52:(4):1997;436-440.
28. Zhang L.F., Zhou J., Chen S., Cai L.L., Bao Q.Y., Zheng F.Y., Lu J.Q., Padmanabha J., Hengst K., Malcolm K., Frazer I.H. HPV6b virus like particles are potent immunogens without adjuvant in man. Vaccine. 18:(11-12):2000;1051-1058.